American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
Am J Health Syst Pharm · Feb 2015
Observational StudyImpact of a clinical pharmacy research team on pharmacy resident research.
A successful initiative by Kaiser Permanente Colorado (KPCO) to support pharmacy resident research projects and the publication of project results in peer-reviewed journals is described. ⋯ An increase in the proportion of pharmacy resident research projects published in peer-reviewed journals was observed after the CPRT was established.
-
Am J Health Syst Pharm · Feb 2015
Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
A cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia (CD) was conducted. ⋯ A cost-utility analysis found that Xeomin was the more cost-effective botulinum toxin type A product compared with Botox and Dysport for the treatment of CD. Wastage associated with the respective products may have a large effect on the cost-effectiveness of the agents.
-
Am J Health Syst Pharm · Feb 2015
Case ReportsUse of low-dose prothrombin complex concentrate before lumbar puncture.
The use of an off-label dose of four-factor prothrombin complex concentrate (PCC) for International Normalized Ratio (INR) reversal in a patient before a diagnostic lumbar puncture is reported. ⋯ A 57-year-old patient was successfully treated with low-dose PCC to reverse an INR from 1.7 to 1.3 in order to perform a diagnostic lumbar puncture.
-
Am J Health Syst Pharm · Feb 2015
Major publications in the critical care pharmacotherapy literature: January-December 2013.
Ten recently published articles with important implications for critical care pharmacotherapy are summarized. ⋯ There were many important additions to the critical care pharmacotherapy literature in 2013, including an updated guideline on the management of myocardial infarction and reports on advances in research focused on improving outcomes in patients with stroke or cardiac arrest and preventing the spread of drug-resistant pathogens in the ICU.